Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(1.42)
# 3,145
Out of 4,814 analysts
462
Total ratings
32.11%
Success rate
-10.29%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IPA ImmunoPrecise Antibodies | Reiterates: Buy | $5 | $0.43 | +1,054.73% | 11 | Apr 11, 2025 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $1.00 | +200.00% | 2 | Apr 4, 2025 | |
| EVAX Evaxion Biotech | Reiterates: Buy | $14 | $1.30 | +976.92% | 12 | Apr 2, 2025 | |
| MDAI Spectral AI | Reiterates: Buy | $3.5 | $1.22 | +186.89% | 4 | Apr 2, 2025 | |
| CELC Celcuity | Reiterates: Buy | $27 | $10.22 | +164.19% | 6 | Apr 1, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $115 → $150 | $62.24 | +141.00% | 21 | Mar 31, 2025 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 | $1.98 | +480.81% | 15 | Mar 28, 2025 | |
| EDAP EDAP TMS | Reiterates: Buy | $19 | $1.38 | +1,276.81% | 14 | Mar 28, 2025 | |
| LPTX Leap Therapeutics | Reiterates: Neutral | n/a | $0.37 | - | 15 | Mar 27, 2025 | |
| XFOR X4 Pharmaceuticals | Reiterates: Buy | $1.5 | $0.19 | +681.25% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $13 | $0.65 | +1,900.00% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $1 | $0.39 | +159.07% | 9 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.09 | +46.28% | 18 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.40 | +330.11% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.10 | +125.81% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.96 | +418.30% | 8 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $14.29 | +130.93% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $7.99 | +150.31% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $0.16 | +3,666.48% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.06 | +312.54% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.60 | +104.08% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.37 | +848.91% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $11.60 | +106.99% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.56 | +792.86% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.65 | +1,124.74% | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $6.45 | +613.18% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.41 | +2,111.85% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $29.66 | +136.01% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $71.73 | +53.35% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.20 | +150.39% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $41.19 | +45.68% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.35 | +348.98% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $1.14 | +382.46% | 6 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.73 | +1,269.86% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.45 | +348.98% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.85 | +170.27% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.95 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.69 | +64.42% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.53 | +1,207.19% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.56 | +252.25% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.51 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.12 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.31 | +587.02% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.56 | +1,507.72% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.53 | +226.80% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.30 | +1,255.93% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.94 | +518.91% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.32 | +6,109.25% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.74 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $0.77 | +10,245.27% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $3.23 | +85.76% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $7.35 | +104.08% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.74 | +475.41% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.54 | -9.82% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $2.14 | +655,637.70% | 1 | Mar 5, 2020 |
ImmunoPrecise Antibodies
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $0.43
Upside: +1,054.73%
RenovoRx
Apr 4, 2025
Reiterates: Buy
Price Target: $3
Current: $1.00
Upside: +200.00%
Evaxion Biotech
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $1.30
Upside: +976.92%
Spectral AI
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.22
Upside: +186.89%
Celcuity
Apr 1, 2025
Reiterates: Buy
Price Target: $27
Current: $10.22
Upside: +164.19%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $115 → $150
Current: $62.24
Upside: +141.00%
Innate Pharma
Mar 28, 2025
Reiterates: Buy
Price Target: $12
Current: $1.98
Upside: +480.81%
EDAP TMS
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.38
Upside: +1,276.81%
Leap Therapeutics
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.37
Upside: -
X4 Pharmaceuticals
Mar 27, 2025
Reiterates: Buy
Price Target: $1.5
Current: $0.19
Upside: +681.25%
Mar 21, 2025
Maintains: Buy
Price Target: $18 → $13
Current: $0.65
Upside: +1,900.00%
Mar 21, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.39
Upside: +159.07%
Mar 20, 2025
Reiterates: Buy
Price Target: $25
Current: $17.09
Upside: +46.28%
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.40
Upside: +330.11%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $3.10
Upside: +125.81%
Mar 19, 2025
Reiterates: Buy
Price Target: $5
Current: $0.96
Upside: +418.30%
Mar 19, 2025
Reiterates: Buy
Price Target: $33
Current: $14.29
Upside: +130.93%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $7.99
Upside: +150.31%
Mar 14, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.16
Upside: +3,666.48%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $6.06
Upside: +312.54%
Mar 12, 2025
Reiterates: Buy
Price Target: $40
Current: $19.60
Upside: +104.08%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.37
Upside: +848.91%
Mar 7, 2025
Maintains: Buy
Price Target: $22 → $24
Current: $11.60
Upside: +106.99%
Mar 7, 2025
Reiterates: Buy
Price Target: $5
Current: $0.56
Upside: +792.86%
Mar 6, 2025
Reiterates: Buy
Price Target: $8
Current: $0.65
Upside: +1,124.74%
Mar 6, 2025
Reiterates: Buy
Price Target: $46
Current: $6.45
Upside: +613.18%
Mar 4, 2025
Reiterates: Buy
Price Target: $9
Current: $0.41
Upside: +2,111.85%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $29.66
Upside: +136.01%
Mar 3, 2025
Reiterates: Buy
Price Target: $110
Current: $71.73
Upside: +53.35%
Feb 28, 2025
Reiterates: Buy
Price Target: $8
Current: $3.20
Upside: +150.39%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $41.19
Upside: +45.68%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.35
Upside: +348.98%
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $1.14
Upside: +382.46%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $0.73
Upside: +1,269.86%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $2.45
Upside: +348.98%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $1.85
Upside: +170.27%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.95
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.69
Upside: +64.42%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $1.53
Upside: +1,207.19%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $2.56
Upside: +252.25%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.51
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.12
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.31
Upside: +587.02%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.56
Upside: +1,507.72%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.53
Upside: +226.80%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.30
Upside: +1,255.93%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.94
Upside: +518.91%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.32
Upside: +6,109.25%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.74
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $0.77
Upside: +10,245.27%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $3.23
Upside: +85.76%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $7.35
Upside: +104.08%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.74
Upside: +475.41%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.54
Upside: -9.82%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $2.14
Upside: +655,637.70%